
John D. Ulm
Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1812, 1646, 1805 |
| Total Applications | 2240 |
| Issued Applications | 1195 |
| Pending Applications | 205 |
| Abandoned Applications | 843 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6063092
[patent_doc_number] => 20110201030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Human G-Protein Chemokine Receptor (CCR5) HDGNR10'
[patent_app_type] => utility
[patent_app_number] => 13/080424
[patent_app_country] => US
[patent_app_date] => 2011-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12922
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201030.pdf
[firstpage_image] =>[orig_patent_app_number] => 13080424
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/080424 | Human G-Protein Chemokine Receptor (CCR5) HDGNR10 | Apr 4, 2011 | Abandoned |
Array
(
[id] => 6174351
[patent_doc_number] => 20110177085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'Bitter Taste Receptors'
[patent_app_type] => utility
[patent_app_number] => 13/071924
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18163
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177085.pdf
[firstpage_image] =>[orig_patent_app_number] => 13071924
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/071924 | Bitter taste receptors | Mar 24, 2011 | Issued |
Array
(
[id] => 7587239
[patent_doc_number] => 20110281749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'HUMAN T2R RECEPTORS FOR ACETAMINOPHEN, RANITIDINE, STRYCHNINE AND DENATONIUM AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/052578
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19699
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281749.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052578
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052578 | Human T2R receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators | Mar 20, 2011 | Issued |
Array
(
[id] => 6101655
[patent_doc_number] => 20110165147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'NOVEL 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 AND 26908 MOLECULES AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/037699
[patent_app_country] => US
[patent_app_date] => 2011-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80459
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165147.pdf
[firstpage_image] =>[orig_patent_app_number] => 13037699
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/037699 | NOVEL 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 AND 26908 MOLECULES AND USES THEREFOR | Feb 28, 2011 | Abandoned |
Array
(
[id] => 6178513
[patent_doc_number] => 20110178274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/037125
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14054
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178274.pdf
[firstpage_image] =>[orig_patent_app_number] => 13037125
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/037125 | CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS | Feb 27, 2011 | Abandoned |
Array
(
[id] => 6080004
[patent_doc_number] => 20110142821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'ROLES FOR DUAL ENDOTHELIN-1/ANGIOTENSIN II RECEPTOR (DEAR) IN HYPERTENSION AND ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 13/030557
[patent_app_country] => US
[patent_app_date] => 2011-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 20339
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142821.pdf
[firstpage_image] =>[orig_patent_app_number] => 13030557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/030557 | ROLES FOR DUAL ENDOTHELIN-1/ANGIOTENSIN II RECEPTOR (DEAR) IN HYPERTENSION AND ANGIOGENESIS | Feb 17, 2011 | Abandoned |
Array
(
[id] => 6188927
[patent_doc_number] => 20110171728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Method and composition for crystallizing G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 12/932075
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14751
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171728.pdf
[firstpage_image] =>[orig_patent_app_number] => 12932075
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/932075 | Method and composition for crystallizing G protein-coupled receptors | Feb 15, 2011 | Issued |
Array
(
[id] => 8221935
[patent_doc_number] => 20120136137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'Method and composition for crystallizing G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 12/932100
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14732
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12932100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/932100 | Method and composition for crystallizing G protein-coupled receptors | Feb 15, 2011 | Issued |
Array
(
[id] => 8020413
[patent_doc_number] => 08139715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Method and composition for crystallizing G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 12/932076
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14731
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/139/08139715.pdf
[firstpage_image] =>[orig_patent_app_number] => 12932076
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/932076 | Method and composition for crystallizing G protein-coupled receptors | Feb 15, 2011 | Issued |
Array
(
[id] => 8177617
[patent_doc_number] => 08178655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Method and composition for crystallizing G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 12/932101
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14736
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178655.pdf
[firstpage_image] =>[orig_patent_app_number] => 12932101
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/932101 | Method and composition for crystallizing G protein-coupled receptors | Feb 15, 2011 | Issued |
Array
(
[id] => 8538503
[patent_doc_number] => 08314224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'T1R taste receptors and genes encoding same'
[patent_app_type] => utility
[patent_app_number] => 13/023836
[patent_app_country] => US
[patent_app_date] => 2011-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27462
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13023836
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/023836 | T1R taste receptors and genes encoding same | Feb 8, 2011 | Issued |
Array
(
[id] => 6212812
[patent_doc_number] => 20110136112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'IDENTIFICATION OF BITTER LIGANDS THAT SPECIFICALLY ACTIVATE HUMAN T2R RECEPTORS AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/019580
[patent_app_country] => US
[patent_app_date] => 2011-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21794
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136112.pdf
[firstpage_image] =>[orig_patent_app_number] => 13019580
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/019580 | Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators | Feb 1, 2011 | Issued |
Array
(
[id] => 6143132
[patent_doc_number] => 20110129848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Antibody Recognizing G Protein, and Agent and Kit Using the Same'
[patent_app_type] => utility
[patent_app_number] => 13/018546
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25694
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13018546
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/018546 | Antibody Recognizing G Protein, and Agent and Kit Using the Same | Jan 31, 2011 | Abandoned |
Array
(
[id] => 6187784
[patent_doc_number] => 20110171205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/012890
[patent_app_country] => US
[patent_app_date] => 2011-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 227279
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171205.pdf
[firstpage_image] =>[orig_patent_app_number] => 13012890
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/012890 | NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR | Jan 24, 2011 | Abandoned |
Array
(
[id] => 6159486
[patent_doc_number] => 20110158978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/977991
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24640
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20110158978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12977991
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977991 | ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS | Dec 22, 2010 | Abandoned |
Array
(
[id] => 8435357
[patent_doc_number] => 08283126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-09
[patent_title] => 'Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/970192
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6452
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12970192
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/970192 | Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof | Dec 15, 2010 | Issued |
Array
(
[id] => 5961052
[patent_doc_number] => 20110185439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'G PROTEIN COUPLED RECEPTORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/970094
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 112627
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20110185439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12970094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/970094 | G PROTEIN COUPLED RECEPTORS AND USES THEREOF | Dec 15, 2010 | Abandoned |
Array
(
[id] => 8689951
[patent_doc_number] => 08389478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Methods and compositions for treating neurodegenerative disorders and Alzheimer\'s disease and improving normal memory'
[patent_app_type] => utility
[patent_app_number] => 12/966969
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 22
[patent_no_of_words] => 22140
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12966969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966969 | Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory | Dec 12, 2010 | Issued |
Array
(
[id] => 9046819
[patent_doc_number] => 08541373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'BChE albumin fusions for the treatment of cocaine abuse'
[patent_app_type] => utility
[patent_app_number] => 12/962410
[patent_app_country] => US
[patent_app_date] => 2010-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 55
[patent_no_of_words] => 21307
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12962410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/962410 | BChE albumin fusions for the treatment of cocaine abuse | Dec 6, 2010 | Issued |
Array
(
[id] => 10026336
[patent_doc_number] => 09068226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Compositions and methods for enhancing odorant receptor activity'
[patent_app_type] => utility
[patent_app_number] => 13/513600
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 72
[patent_no_of_words] => 45959
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/513600 | Compositions and methods for enhancing odorant receptor activity | Dec 5, 2010 | Issued |